One study (48) showed that HMGCR moderate/strong expression was associated with prognostically adverse tumour characteristics (higher histological grade, high Ki67, and ER negativity) and that neither HMGCR expression nor statin use was associated with breast cancer mortality (48). The gene discussed is HMGCR; the disease is breast cancer.